The clearance allows the system to offer personalised insights for individuals managing diabetes through MDI therapies.
The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous ...
The InPen app paves the way for the launch of the company’s “Smart MDI” system combining a smart insulin pen that tracks ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) ...
With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete ...
This latest FDA clearance should pave the way for the launch of the company’s Smart MDI system, which combines the InPen ...
It combines the company’s InPen smart insulin pen with its Simplera continuous glucose monitor (CGM), a disposable, all-in-one device. The MDI system is poised to be the first on the market to ...
Medtronic (MDT) announced FDA clearance for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart ...